SCIENTIFIC BACKGROUND

AKT1, ALK, BRAF, CTNNB1, ERBB2, FGFR1, FGFR2, FGFR3, GNA11, GNAQ, KIT, KRAS, MAP2K1, MET, MYC, NF1, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, POLE, PTEN, RET, ROS1, STK11, TP53

Category:

Scientific Background

Melanoma is a malignant type of skin cancer that arises from cells in the skin, the melanocytes. It is the 17th most common type of cancer worldwide. In 2020, there were more than 300,000 new cases diagnosed with melanoma. Factors such as environmental and inheritance can increase the risk of developing melanoma. Accumulation of genetic alterations (mutations) in the DNA can result in melanoma initiation and development. Mutations in genes including BRAF, NRAS and others are frequently found in patients with melanoma. Identification of mutations found in circulating tumor DNA, which is released from these tumors, can have huge potential and can provide the necessary information about the genetic characteristics of the tumor, therefore having a prognostic and therapeutic value. Personalized medicine tailored to each patient can be beneficial for increasing the chances of melanoma treatment depending on the unique mutations in each cancer patient. Indeed, over the last decade novel personalized therapeutic opportunities have been developed and currently, there are different FDA/EMA approved drugs for melanoma including vemurafenib.

 

This panel also test for Microsatellite instability (MSI) immunotherapy biomarker. Studies show that MSI is frequently found in melanoma patients and can be a predictive factor for identifying patients who might respond to immunotherapy. The FDA approved drug pembrolizumab can be used as an immunotherapy option for melanoma patients with MSI-high status.

 

How many genes are tested in this panel?

28 genes

 

References and more information: 

 

Information obtained from professional bodies including National Cancer Institute, and World Cancer Research Fund International

Kubeček O, Kopecký J. Microsatellite instability in melanoma: a comprehensive review. Melanoma Res. 2016 Dec;26(6):545-550. doi: 10.1097/CMR.0000000000000298. PMID: 27623135.

Alvino E, Passarelli F, Cannavò E, Fortes C, Mastroeni S, Caporali S, Jiricny J, Cappellini GC, Scoppola A, Marchetti P, Modesti A, D'Atri S. High expression of the mismatch repair protein MSH6 is associated with poor patient survival in melanoma. Am J Clin Pathol. 2014 Jul;142(1):121-32. doi: 10.1309/AJCPCX2D9YULBBLG. PMID: 24926095.

GENES

AKT1, ALK, BRAF, CTNNB1, ERBB2, FGFR1, FGFR2, FGFR3, GNA11, GNAQ, KIT, KRAS, MAP2K1, MET, MYC, NF1, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, POLE, PTEN, RET, ROS1, STK11, TP53
How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more